Rose Ackermann

1.3k total citations
29 papers, 983 citations indexed

About

Rose Ackermann is a scholar working on Pharmaceutical Science, Molecular Biology and Surgery. According to data from OpenAlex, Rose Ackermann has authored 29 papers receiving a total of 983 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmaceutical Science, 9 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Rose Ackermann's work include Advanced Drug Delivery Systems (13 papers), Drug Solubulity and Delivery Systems (8 papers) and Lipoproteins and Cardiovascular Health (5 papers). Rose Ackermann is often cited by papers focused on Advanced Drug Delivery Systems (13 papers), Drug Solubulity and Delivery Systems (8 papers) and Lipoproteins and Cardiovascular Health (5 papers). Rose Ackermann collaborates with scholars based in United States, China and Germany. Rose Ackermann's co-authors include Anna Schwendeman, Karl Olsen, Steven P. Schwendeman, Jia Zhou, Jennifer Walker, Keiji Hirota, Stephanie Choi, Justin K. Y. Hong, Jie Tang and Yan Wang and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Biomaterials.

In The Last Decade

Rose Ackermann

29 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rose Ackermann United States 19 324 318 226 209 140 29 983
Minzhi Yu United States 17 128 0.4× 632 2.0× 398 1.8× 117 0.6× 86 0.6× 38 1.3k
Sharon Pangburn United States 8 97 0.3× 329 1.0× 181 0.8× 207 1.0× 109 0.8× 8 854
Mengyao Qin China 17 297 0.9× 440 1.4× 111 0.5× 44 0.2× 31 0.2× 34 1.2k
Juan Cheng China 19 51 0.2× 342 1.1× 104 0.5× 132 0.6× 65 0.5× 48 1.3k
Donghang Xu China 17 124 0.4× 449 1.4× 216 1.0× 42 0.2× 20 0.1× 54 995
Huijie An China 11 74 0.2× 298 0.9× 178 0.8× 121 0.6× 36 0.3× 17 1.0k
Emily E. Morin United States 12 43 0.1× 394 1.2× 302 1.3× 226 1.1× 155 1.1× 21 1.0k
Maha M. Amin Egypt 20 483 1.5× 248 0.8× 142 0.6× 56 0.3× 25 0.2× 47 1.1k
Bo Lundberg Finland 16 65 0.2× 348 1.1× 128 0.6× 208 1.0× 33 0.2× 32 766
Sachin Mittal India 15 131 0.4× 243 0.8× 73 0.3× 49 0.2× 30 0.2× 61 734

Countries citing papers authored by Rose Ackermann

Since Specialization
Citations

This map shows the geographic impact of Rose Ackermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose Ackermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose Ackermann more than expected).

Fields of papers citing papers by Rose Ackermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rose Ackermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose Ackermann. The network helps show where Rose Ackermann may publish in the future.

Co-authorship network of co-authors of Rose Ackermann

This figure shows the co-authorship network connecting the top 25 collaborators of Rose Ackermann. A scholar is included among the top collaborators of Rose Ackermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rose Ackermann. Rose Ackermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Ziyi, et al.. (2025). A Comparative Study on Physicochemical and Analytical Characterizations of Doxil® and its Generic Drug Products. The AAPS Journal. 27(4). 100–100. 1 indexed citations
2.
Ackermann, Rose, Minzhi Yu, Xinye Wang, et al.. (2024). Reverse engineering of Onivyde® – Irinotecan liposome injection. International Journal of Pharmaceutics. 669. 125000–125000. 6 indexed citations
3.
Walker, Jennifer L., et al.. (2024). Effect of PLGA raw materials on in vitro and in vivo performance of drug-loaded microspheres. Drug Delivery and Translational Research. 15(1). 185–202. 3 indexed citations
4.
Shi, Nianqiu, Karl Olsen, Rose Ackermann, et al.. (2023). Mechanistic evaluation of the initial burst release of leuprolide from spray-dried PLGA microspheres. Journal of Controlled Release. 361. 297–313. 23 indexed citations
5.
Yuan, Wenmin, Rui Kuai, Emily E. Morin, et al.. (2022). Systematic evaluation of the effect of different apolipoprotein A-I mimetic peptides on the performance of synthetic high-density lipoproteins in vitro and in vivo. Nanomedicine Nanotechnology Biology and Medicine. 48. 102646–102646. 10 indexed citations
6.
Zhou, Jia, Nianqiu Shi, Rose Ackermann, et al.. (2022). Influence of encapsulation variables on formation of leuprolide-loaded PLGA microspheres. Journal of Colloid and Interface Science. 636. 401–412. 10 indexed citations
7.
Beig, Avital, Linglin Feng, Jennifer Walker, et al.. (2021). Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method. Drug Delivery and Translational Research. 12(3). 695–707. 9 indexed citations
8.
Zhou, Jia, Jennifer Walker, Rose Ackermann, et al.. (2020). Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide. Molecular Pharmaceutics. 17(5). 1502–1515. 51 indexed citations
9.
Beig, Avital, Linglin Feng, Jennifer Walker, et al.. (2020). Physical–Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres. Molecular Pharmaceutics. 17(11). 4141–4151. 32 indexed citations
10.
Liu, Yayuan, Zihan Mei, Ling Mei, et al.. (2020). Analytical method development and comparability study for AmBisome® and generic Amphotericin B liposomal products. European Journal of Pharmaceutics and Biopharmaceutics. 157. 241–249. 19 indexed citations
11.
Shi, Nianqiu, Jia Zhou, Jennifer Walker, et al.. (2020). Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray-drying. Journal of Controlled Release. 321. 756–772. 67 indexed citations
12.
Li, Tinghui, Avital Beig, Jennifer Walker, et al.. (2020). Characterization of attributes and in vitro performance of exenatide-loaded PLGA long-acting release microspheres. European Journal of Pharmaceutics and Biopharmaceutics. 158. 401–409. 33 indexed citations
13.
Zhou, Jia, Keiji Hirota, Rose Ackermann, et al.. (2018). Reverse Engineering the 1-Month Lupron Depot®. The AAPS Journal. 20(6). 105–105. 41 indexed citations
14.
Doty, Amy C., Keiji Hirota, Karl Olsen, et al.. (2016). Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres. Biomaterials. 109. 88–96. 25 indexed citations
15.
Tang, Jie, Dan Li, Lindsey Drake, et al.. (2016). Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization. Journal of Lipid Research. 58(1). 124–136. 27 indexed citations
16.
Bisgaier, Charles L., et al.. (2016). ApoA-IMilano phospholipid complex (ETC-216) infusion in human volunteers. Insights into the phenotypic characteristics of ApoA-IMilano carriers. Pharmacological Research. 111. 86–99. 16 indexed citations
17.
Yuan, Yue, Jian Wen, Jie Tang, et al.. (2016). Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin. International Journal of Nanomedicine. Volume 11. 6229–6238. 38 indexed citations
18.
Tardy, Claudine, Nadia Boubekeur, Rose Ackermann, et al.. (2015). HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation. PLoS ONE. 10(9). e0137584–e0137584. 26 indexed citations
19.
Tardy, Claudine, Nadia Boubekeur, Rose Ackermann, et al.. (2013). CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice. Atherosclerosis. 232(1). 110–118. 92 indexed citations
20.
Cramer, Clay T., Brian D. Goetz, Gregory J. Fici, et al.. (2004). Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome. Journal of Lipid Research. 45(7). 1289–1301. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minzhi Yu Breakdown of academic impact, for papers by Sharon Pangburn Breakdown of academic impact, for papers by Mengyao Qin Breakdown of academic impact, for papers by Juan Cheng Breakdown of academic impact, for papers by Donghang Xu Breakdown of academic impact, for papers by Huijie An Breakdown of academic impact, for papers by Emily E. Morin Breakdown of academic impact, for papers by Maha M. Amin Breakdown of academic impact, for papers by Bo Lundberg Breakdown of academic impact, for papers by Sachin Mittal
Rankless by CCL
2026